BALFX
Price
$39.00
Change
+$0.07 (+0.18%)
Updated
Oct 6 closing price
Net Assets
265.73B
TSHIX
Price
$15.97
Change
+$0.02 (+0.13%)
Updated
Oct 6 closing price
Net Assets
830.41M
Interact to see
Advertisement

BALFX vs TSHIX

Header iconBALFX vs TSHIX Comparison
Open Charts BALFX vs TSHIXBanner chart's image
American Funds American Balanced F1
Price$39.00
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets265.73B
Transamerica Multi-Asset Income I
Price$15.97
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets830.41M
BALFX vs TSHIX Comparison Chart in %
View a ticker or compare two or three
VS
BALFX vs. TSHIX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and TSHIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 266B vs. TSHIX (830M). TSHIX pays higher dividends than BALFX: TSHIX (3.46) vs BALFX (1.72). BALFX was incepted earlier than TSHIX: BALFX (25 years) vs TSHIX (12 years). TSHIX (0.73) is less costly to investors than BALFX (0.61). BALFX (44.00) and TSHIX (42.00) have comparable annual turnover. BALFX has a lower initial minimum investment than TSHIX: BALFX (250) vs TSHIX (1000000). TSHIX annual gain was more profitable for investors over the last year : 14.23 vs. BALFX (9.60). TSHIX return over 5 years is better than : 60.38 vs. BALFX (43.49).
BALFXTSHIXBALFX / TSHIX
Total Expense Ratio0.610.7285%
Annual Report Gross Expense Ratio0.610.7384%
Fund Existence25 years12 years-
Gain YTD14.69213.036113%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets266B830M32,048%
Annual Yield % from dividends1.723.4650%
Returns for 1 year9.6014.2367%
Returns for 3 years51.3948.88105%
Returns for 5 years43.4960.3872%
Returns for 10 years76.84117.0766%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMX5.310.34
+6.84%
EMX Royalty Corp
SMMT22.150.72
+3.36%
Summit Therapeutics
TUSK2.30N/A
N/A
Mammoth Energy Services
HURN150.20-0.12
-0.08%
Huron Consulting Group
APRE1.49-0.02
-1.00%
Aprea Therapeutics